Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation
Crossref DOI link: https://doi.org/10.1007/s00277-020-04033-2
Published Online: 2020-05-07
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pasic, Ivan
Lipton, Jeffrey H.
Kim, Dennis D.
Viswabandya, Auro
Kumar, Rajat
Lam, Wilson
Law, Arjun D.
Mattsson, Jonas
Michelis, Fotios V.
Text and Data Mining valid from 2020-05-07
Version of Record valid from 2020-05-07
Article History
Received: 16 October 2019
Accepted: 10 April 2020
First Online: 7 May 2020